Everand Logo

Welcome to Everand!

  • Discover this podcast and so much more

    Podcasts are free to enjoy without a subscription. We also offer ebooks, audiobooks, and so much more for just $11.99/month.

    Vor Biopharma's CEO on Genome Engineering of Hematopoietic Stem Cells

    Vor Biopharma's CEO on Genome Engineering of Hematopoietic Stem Cells

    FromCell & Gene: The Podcast

    Start listeningView podcast show

    Vor Biopharma's CEO on Genome Engineering of Hematopoietic Stem Cells

    FromCell & Gene: The Podcast

    ratings:
    Length:
    19 minutes
    Released:
    Dec 22, 2021
    Format:
    Podcast episode

    Description

    Vor Biopharma's CEO Dr. Robert Ang explains the company's lead engineered hematopoietic cell (eHSC) product candidate, genome engineering of HSCs, and the cell manufacturing process needed to leverage genome engineering technologies for the cells they're creating.
    Released:
    Dec 22, 2021
    Format:
    Podcast episode

    Titles in the series (76)

    Cell & Gene, the most valuable online resource for delivering in-depth content from authoritative authors and sources to professionals in the CGT sector, introduces Cell & Gene: The Podcast. In each episode, Cell & Gene Chief Editor, Erin Harris, will talk to industry and academic leaders about their current initiatives and how they are moving the sector forward.